Expanded use trials-are there better approaches to minimize adverse consequences to the clinical trials program?

Cancer J. 2014 Jan-Feb;20(1):25-6. doi: 10.1097/PPO.0000000000000022.
No abstract available

Publication types

  • Comment

MeSH terms

  • Female
  • Humans
  • Indoles / therapeutic use*
  • Male
  • Melanoma / drug therapy*
  • Skin Neoplasms / drug therapy*
  • Sulfonamides / therapeutic use*
  • Vemurafenib

Substances

  • Indoles
  • Sulfonamides
  • Vemurafenib